Pages that link to "Q45928387"

The following pages link to Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma. (Q45928387):

Displaying 18 items.

• Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer. (Q33688577) (← links)
• Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update (Q33805874) (← links)
• Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients (Q35753837) (← links)
• P-mTOR Expression and Implication in Breast Carcinoma: A Systematic Review and Meta-Analysis (Q36257635) (← links)
• Molecular genetics and targeted therapeutics in biliary tract carcinoma (Q36488070) (← links)
• Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice (Q36544718) (← links)
• AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines (Q37225342) (← links)
• Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer (Q38903263) (← links)
• Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition (Q39016105) (← links)
• Biliary tract cancer stem cells - translational options and challenges. (Q39279276) (← links)
• Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients (Q41913207) (← links)
• Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy-naïve pT2 gallbladder adenocarcinoma patients. (Q44712013) (← links)
• Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. (Q48378601) (← links)
• A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks. (Q52950022) (← links)
• Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. (Q55481891) (← links)
• Targeting gallbladder cancer: a pathway based perspective (Q89533973) (← links)
• mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance (Q92591525) (← links)
• Overview of current targeted therapy in gallbladder cancer (Q100490609) (← links)